New Queen's spin-in company to revolutionise cancer detection
Posted on Tuesday 17th July 2012
The development of novel medical imaging techniques to revolutionise cancer detection and treatment will be the result of a new partnership announced between Queen's University Belfast and Cirdan Imaging Ltd.
The research will focus on developing new imaging equipment using X-rays and near Infrared (NIR) Fluorescence to assist clinicians in the detection, diagnosis and treatment of cancer.
Complete surgical removal of a tumour is vital for the patient, and one of the most important prognostic factors for survival. The new devices will be used in diagnostic procedures, as well as cancer surgery, to better discriminate between healthy and malignant tissue.
Queen's University have taken an equity shareholding in Cirdan Imaging Ltd through its venture spin-out company QUBIS Ltd, representing their first ever company spin-in.